Compile Data Set for Download or QSAR
maximum 50k data
Found 130 with Last Name = 'bardiot' and Initial = 'd'
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126682(US8785638, 170)
Affinity DataIC50:  50nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459192(CHEMBL4205724)
Affinity DataIC50:  50nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126676(US8785638, 161)
Affinity DataIC50:  55.4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126692(US8785638, 190)
Affinity DataIC50:  370nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126690(US8785638, 186)
Affinity DataIC50:  430nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126634(US8785638, 116)
Affinity DataIC50:  620nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126631(US8785638, 113 | US8785638, 142)
Affinity DataIC50:  750nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126635(US8785638, 117)
Affinity DataIC50:  780nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126679(US8785638, 165)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126632(US8785638, 114)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126685(US8785638, 175)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126630(US8785638, 112)
Affinity DataIC50:  1.11E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126683(US8785638, 171)
Affinity DataIC50:  1.21E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126666(US8785638, 150)
Affinity DataIC50:  1.37E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 1A2(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459193(CHEMBL4212403)
Affinity DataIC50:  1.40E+3nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459193(CHEMBL4212403)
Affinity DataIC50:  1.40E+3nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126677(US8785638, 162)
Affinity DataIC50:  1.57E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126664(US8785638, 148)
Affinity DataIC50:  2.19E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 2C19(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459193(CHEMBL4212403)
Affinity DataIC50:  2.30E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459193(CHEMBL4212403)
Affinity DataIC50:  2.30E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459192(CHEMBL4205724)
Affinity DataIC50:  2.50E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126637(US8785638, 119)
Affinity DataIC50:  2.66E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126638(US8785638, 120)
Affinity DataIC50:  2.72E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 1A2(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459192(CHEMBL4205724)
Affinity DataIC50:  2.80E+3nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126643(US8785638, 127)
Affinity DataIC50:  2.85E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126680(US8785638, 166)
Affinity DataIC50:  3.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 2C9(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459193(CHEMBL4212403)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459193(CHEMBL4212403)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459193(CHEMBL4212403)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459194(CHEMBL4203293)
Affinity DataIC50:  3.10E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126639(US8785638, 122)
Affinity DataIC50:  3.20E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 2C19(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459195(CHEMBL4203720)
Affinity DataIC50:  3.20E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459193(CHEMBL4212403)
Affinity DataIC50:  3.20E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459192(CHEMBL4205724)
Affinity DataIC50:  3.30E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126689(US8785638, 184)
Affinity DataIC50:  3.44E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459192(CHEMBL4205724)
Affinity DataIC50:  3.50E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459195(CHEMBL4203720)
Affinity DataIC50:  4.20E+3nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126629(US8785638, 110)
Affinity DataIC50:  4.31E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126652(US8785638, 136)
Affinity DataIC50:  4.34E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 2C19(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459194(CHEMBL4203293)
Affinity DataIC50:  4.40E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126627(US8785638, 108)
Affinity DataIC50:  4.48E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126678(US8785638, 163)
Affinity DataIC50:  4.50E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126647(US8785638, 131)
Affinity DataIC50:  4.54E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126662(US8785638, 146)
Affinity DataIC50:  4.76E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126684(US8785638, 173)
Affinity DataIC50:  5.90E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 2C9(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459195(CHEMBL4203720)
Affinity DataIC50:  6.10E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Cistim Leuven

Curated by ChEMBL
LigandPNGBDBM50459193(CHEMBL4212403)
Affinity DataIC50:  6.40E+3nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126622(US8785638, 100)
Affinity DataIC50:  6.61E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126660(US8785638, 144)
Affinity DataIC50:  6.64E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126628(US8785638, 109)
Affinity DataIC50:  6.81E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 130 total ) | Next | Last >>
Jump to: